A catecholamine model of fatigue.
I
I
Hickie
A
A
Wilson
D000203:Activities of Daily Living / Q000523:psychology; D000293:Adolescent; D000328:Adult; D000368:Aged; D001549:Benzamides / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D002395:Catecholamines / Q000502:physiology*; D003866:Depressive Disorder / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use
D001549:Benzamides; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D005473:Fluoxetine; D020912:Moclobemide